PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24812692-9	2014	RESULTS: Treatment with NPH improved insulin secretion from beta-cells during the IPGTT and increased pancreatic islet size.	Insulin, Isophane	24-27	insulin	Homo sapiens	37-44	
24843464-2	2011	MATERIALS AND METHODS:   We carried out a retrospective study to compare the effects of replacing NPH with detemir in basal-bolus insulin therapy in Japanese patients with type 1 diabetes.	Insulin, Isophane	98-101	insulin	Homo sapiens	130-137	
20678116-1	2010	AIMS: The aim of study was to evaluate the safety and efficacy of insulin detemir as a basal insulin switching from neutral protamine Hagedorn insulin (NPH) and insulin glargine in patients with diabetes on an intensive insulin therapy regimen.	Insulin, Isophane	152-155	insulin	Homo sapiens	66-73	
20678116-5	2010	However, significant improvement was seen only among the patients who had previously used NPH as a basal insulin.	Insulin, Isophane	90-93	insulin	Homo sapiens	105-112	
17565917-5	2007	Treatment with insulin detemir+/-OHA was associated with increases in quality-adjusted life expectancy of 0.309, 0.350, and 0.333 quality-adjusted life-years (QALYs) versus treatment with OHA alone, NPH+/-OHA, and insulin glargine+/-OHA, respectively.	Insulin, Isophane	199-202	insulin	Homo sapiens	15-22	
15498377-5	2004	A group of diabetic rats was then injected with protamine zinc insulin [PZI, 1 - 2 U x kg(-1) x d(-1)] for one week.	Insulin, Isophane	72-75	insulin	Homo sapiens	63-70	
10638500-8	1999	CONCLUSION: In streptozotocin-diabetic rats, normal weight gain can be achieved by treatment with PZI insulin once daily, but attainment of near-normal glucose values requires administration of PZI, NPH, or 70/ 30 insulin twice daily.	Insulin, Isophane	98-101	insulin	Homo sapiens	102-109	
6850362-6	1983	Among these insulin treated groups, the PZI-treated group showed the greatest number of degenerating profiles while the minipump group showed the least.	Insulin, Isophane	40-43	insulin	Homo sapiens	12-19	
31768180-7	2019	Results: Availability in public pharmacies is 63.2% for regular insulin and 68.4% for NPH (isophane) insulin, but differences in availability were observed between levels of care and between regions.	Insulin, Isophane	91-99	insulin	Homo sapiens	101-108	
28230445-12	2017	In general, for both existing and new basal insulin users, higher persistence rate and duration were associated with Medicare versus cash-pay patients, use of insulin pens versus vial/syringe, and use of insulin glargine versus NPH.	Insulin, Isophane	228-231	insulin	Homo sapiens	44-51